FindTrial
Sign In

Gut Microbiome Regulation and Chronic Kidney Failure Improvement.

Microbiome and metabolite mechanisms for improvement of chronic kidney loss through intestinal microbiome modulation.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0010372
Enrollment
20
Registered
2025-04-01
Start date
2025-03-19
Completion date
Unknown
Last updated
2025-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Inha University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: A. recurrent Clostridioides difficile infection, CDI chronic kidney disease (CKD stage 4 eGFR <30 mL/min/1.73m2) B. Kidney function at least 1 month ago (Bun. Creatinine)

Exclusion criteria

Exclusion criteria: - Pregnant or potentially pregnant patients during the study period. - Patients with severe systemic diseases deemed inappropriate by the investigator. - Patients who do not consent to participate in the study. - Those who have not had a renal function evaluation at least 1 month prior to FMT.

Design outcomes

Primary

MeasureTime frame
Difference in eGFR Changes—

Secondary

MeasureTime frame
Difference in BUN/Creatinine Changes;Urine Protein and Urine Creatinine/Albumin Ratio;Differences in Fecal Microbiome Composition (e.g., alpha diversity, beta diversity);Differences in Blood and Urine Metabolite Profiles;Incidence Rate of Complications—

Countries

Korea, Republic of

Contacts

Public ContactJung Hwan Lee

Inha University Hospital

endlesmile@naver.com+82-32-890-3557

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026